196 related articles for article (PubMed ID: 19552546)
1. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
Shakeel F; Faisal MS
Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
[TBL] [Abstract][Full Text] [Related]
2. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
[TBL] [Abstract][Full Text] [Related]
4. Caffeine: a potential complexing agent for solubility and dissolution enhancement of celecoxib.
Shakeel F; Faisal MS
Pharm Biol; 2010 Jan; 48(1):113-5. PubMed ID: 20645765
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation.
Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW
Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
7. Criterion for excipients screening in the development of nanoemulsion formulation of three anti-inflammatory drugs.
Shakeel F
Pharm Dev Technol; 2010; 15(2):131-8. PubMed ID: 19911951
[TBL] [Abstract][Full Text] [Related]
8. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
9. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
10. Topical delivery of celecoxib using microemulsion.
Subramanian N; Ghosal SK; Moulik SP
Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
[TBL] [Abstract][Full Text] [Related]
11. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
[TBL] [Abstract][Full Text] [Related]
12. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib.
McDonald BF; Coulter IS; Marison IW
Pharm Dev Technol; 2015 Mar; 20(2):211-8. PubMed ID: 24283499
[TBL] [Abstract][Full Text] [Related]
13. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib.
Tamilvanan S; Baskar R
Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying core.
Homar M; Dreu R; Kerc J; Gasperlin M
J Microencapsul; 2009 Sep; 26(6):479-84. PubMed ID: 19694601
[TBL] [Abstract][Full Text] [Related]
16. Chemical and in vitro enzymatic stability of newly synthesized celecoxib lipophilic and hydrophilic amides.
Qandil AM; El Mohtadi FH; Tashtoush BM
Int J Pharm; 2011 Sep; 416(1):85-96. PubMed ID: 21704141
[TBL] [Abstract][Full Text] [Related]
17. Preparation of microspheres containing low solubility drug compound by electrohydrodynamic spraying.
Bohr A; Kristensen J; Stride E; Dyas M; Edirisinghe M
Int J Pharm; 2011 Jun; 412(1-2):59-67. PubMed ID: 21511018
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment.
Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
J Drug Target; 2008 Dec; 16(10):733-40. PubMed ID: 18985507
[TBL] [Abstract][Full Text] [Related]
19. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
20. Design and optimization of a new self-nanoemulsifying drug delivery system.
Wang L; Dong J; Chen J; Eastoe J; Li X
J Colloid Interface Sci; 2009 Feb; 330(2):443-8. PubMed ID: 19038395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
